Taiko Pharmaceutical Co.,Ltd. (TYO:4574)
Japan
· Delayed Price · Currency is JPY 295.00
+5.00 (1.72%)
Mar 10, 2026, 11:26 AM JST
Taiko Pharmaceutical Cash Flow Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 923 | 565 | -3,563 | -4,869 | -8,887 | Upgrade
|
| Depreciation & Amortization | 265 | 256 | 704 | 737 | 941 | Upgrade
|
| Loss (Gain) From Sale of Assets | 6 | 240 | 2,430 | 98 | 2,456 | Upgrade
|
| Asset Writedown & Restructuring Costs | 20 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -347 | -6 | -193 | 76 | -60 | Upgrade
|
| Other Operating Activities | -76 | 171 | -602 | -1,101 | -1,023 | Upgrade
|
| Change in Accounts Receivable | -23 | -411 | -175 | 2,315 | 3,899 | Upgrade
|
| Change in Inventory | 57 | -301 | 581 | 1,257 | 3,222 | Upgrade
|
| Change in Accounts Payable | 77 | -150 | 308 | -1,177 | -2,932 | Upgrade
|
| Change in Other Net Operating Assets | -88 | -2 | 203 | 670 | 789 | Upgrade
|
| Operating Cash Flow | 814 | 362 | -307 | -1,994 | -1,595 | Upgrade
|
| Operating Cash Flow Growth | 124.86% | - | - | - | - | Upgrade
|
| Capital Expenditures | -291 | -157 | -97 | -64 | -1,476 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 170 | 2 | - | Upgrade
|
| Cash Acquisitions | - | - | - | -9 | -107 | Upgrade
|
| Sale (Purchase) of Intangibles | -13 | -30 | -17 | -20 | -124 | Upgrade
|
| Investment in Securities | 447 | 266 | 1,105 | 283 | 85 | Upgrade
|
| Other Investing Activities | -1 | -84 | 5 | -2 | - | Upgrade
|
| Investing Cash Flow | 142 | -5 | 1,166 | 190 | -1,622 | Upgrade
|
| Long-Term Debt Issued | - | - | 500 | - | 5,000 | Upgrade
|
| Long-Term Debt Repaid | -1,226 | -1,206 | -1,053 | -923 | -316 | Upgrade
|
| Net Debt Issued (Repaid) | -1,226 | -1,206 | -553 | -923 | 4,684 | Upgrade
|
| Issuance of Common Stock | - | 59 | 2,132 | - | 101 | Upgrade
|
| Common Dividends Paid | - | -1 | -1 | - | -782 | Upgrade
|
| Other Financing Activities | -1 | -33 | -39 | -74 | -44 | Upgrade
|
| Financing Cash Flow | -1,227 | -1,181 | 1,539 | -997 | 3,959 | Upgrade
|
| Foreign Exchange Rate Adjustments | -5 | 112 | 49 | 76 | 82 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | 1 | -1 | Upgrade
|
| Net Cash Flow | -276 | -712 | 2,447 | -2,724 | 823 | Upgrade
|
| Free Cash Flow | 523 | 205 | -404 | -2,058 | -3,071 | Upgrade
|
| Free Cash Flow Growth | 155.12% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 8.18% | 3.26% | -6.60% | -40.83% | -27.18% | Upgrade
|
| Free Cash Flow Per Share | 10.41 | 4.08 | -8.53 | -47.20 | -70.58 | Upgrade
|
| Cash Interest Paid | 5 | 8 | 8 | 10 | 6 | Upgrade
|
| Cash Income Tax Paid | 34 | 30 | - | 23 | 1,030 | Upgrade
|
| Levered Free Cash Flow | 368.75 | -328.25 | 470.25 | 721 | -656.63 | Upgrade
|
| Unlevered Free Cash Flow | 371.88 | -323.25 | 475.25 | 727.25 | -652.88 | Upgrade
|
| Change in Working Capital | 23 | -864 | 917 | 3,065 | 4,978 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.